BPG is committed to discovery and dissemination of knowledge
Cited by in F6Publishing
For: Lantz M, Thysell H, Nilsson E, Olsson I. On the binding of tumor necrosis factor (TNF) to heparin and the release in vivo of the TNF-binding protein I by heparin. J Clin Invest. 1991;88:2026-2031. [PMID: 1752960 DOI: 10.1172/jci115530] [Cited by in Crossref: 99] [Cited by in F6Publishing: 91] [Article Influence: 3.3] [Reference Citation Analysis]
Number Citing Articles
1 Kang I, Chang MY, Wight TN, Frevert CW. Proteoglycans as Immunomodulators of the Innate Immune Response to Lung Infection. J Histochem Cytochem 2018;66:241-59. [PMID: 29328866 DOI: 10.1369/0022155417751880] [Cited by in Crossref: 20] [Cited by in F6Publishing: 26] [Article Influence: 5.0] [Reference Citation Analysis]
2 Chiodelli P, Bugatti A, Urbinati C, Rusnati M. Heparin/Heparan sulfate proteoglycans glycomic interactome in angiogenesis: biological implications and therapeutical use. Molecules 2015;20:6342-88. [PMID: 25867824 DOI: 10.3390/molecules20046342] [Cited by in Crossref: 84] [Cited by in F6Publishing: 86] [Article Influence: 12.0] [Reference Citation Analysis]
3 Byun S, Sinskey YL, Lu YC, Frank EH, Grodzinsky AJ. Transport and binding of tumor necrosis factor-α in articular cartilage depend on its quaternary structure. Arch Biochem Biophys 2013;540:1-8. [PMID: 24135706 DOI: 10.1016/j.abb.2013.10.003] [Cited by in Crossref: 4] [Cited by in F6Publishing: 4] [Article Influence: 0.4] [Reference Citation Analysis]
4 Nässberger L. Serum levels of interleukin-6 are not dependent on the kidney function. Mediators Inflamm 1992;1:197-9. [PMID: 18475461 DOI: 10.1155/S0962935192000309] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.1] [Reference Citation Analysis]
5 Hofstra JJ, Vlaar AP, Prins DJ, Koh G, Levi M, Schultz MJ, Binnekade JM, Juffermans NP. Early intravenous unfractionated heparin and outcome in acute lung injury and acute respiratory distress syndrome: a retrospective propensity matched cohort study. BMC Pulm Med 2012;12:43. [PMID: 22894723 DOI: 10.1186/1471-2466-12-43] [Cited by in Crossref: 7] [Cited by in F6Publishing: 5] [Article Influence: 0.7] [Reference Citation Analysis]
6 Teng YH, Aquino RS, Park PW. Molecular functions of syndecan-1 in disease. Matrix Biol. 2012;31:3-16. [PMID: 22033227 DOI: 10.1016/j.matbio.2011.10.001] [Cited by in Crossref: 194] [Cited by in F6Publishing: 188] [Article Influence: 17.6] [Reference Citation Analysis]
7 Hayashida K, Chen Y, Bartlett AH, Park PW. Syndecan-1 is an in vivo suppressor of Gram-positive toxic shock. J Biol Chem 2008;283:19895-903. [PMID: 18499671 DOI: 10.1074/jbc.M801614200] [Cited by in Crossref: 31] [Cited by in F6Publishing: 27] [Article Influence: 2.2] [Reference Citation Analysis]
8 Bode L, Salvestrini C, Park PW, Li JP, Esko JD, Yamaguchi Y, Murch S, Freeze HH. Heparan sulfate and syndecan-1 are essential in maintaining murine and human intestinal epithelial barrier function. J Clin Invest 2008;118:229-38. [PMID: 18064305 DOI: 10.1172/JCI32335] [Cited by in Crossref: 94] [Cited by in F6Publishing: 93] [Article Influence: 6.7] [Reference Citation Analysis]
9 Ji SL, Cui HF, Shi F, Chi YQ, Cao JC, Geng MY, Guan HS. Inhibitory effect of heparin-derived oligosaccharides on secretion of interleukin-4 and interleukin-5 from human peripheral blood T lymphocytes. World J Gastroenterol 2004; 10(23): 3490-3494 [PMID: 15526371 DOI: 10.3748/wjg.v10.i23.3490] [Cited by in CrossRef: 8] [Cited by in F6Publishing: 7] [Article Influence: 0.4] [Reference Citation Analysis]
10 Dobosz M, Mionskowska L, Hać S, Dobrowolski S, Dymecki D, Wajda Z. Heparin improves organ microcirculatory disturbances in caerulein-induced acute pancreatitis in rats. World J Gastroenterol 2004; 10(17): 2553-2556 [PMID: 15300904 DOI: 10.3748/wjg.v10.i17.2553] [Cited by in CrossRef: 9] [Cited by in F6Publishing: 12] [Article Influence: 0.5] [Reference Citation Analysis]
11 Brooks BM, Thomas AL, Coleman JW. Benzylpenicillin differentially conjugates to IFN-gamma, TNF-alpha, IL-1beta, IL-4 and IL-13 but selectively reduces IFN-gamma activity. Clin Exp Immunol 2003;131:268-74. [PMID: 12562387 DOI: 10.1046/j.1365-2249.2003.02069.x] [Cited by in Crossref: 17] [Cited by in F6Publishing: 15] [Article Influence: 0.9] [Reference Citation Analysis]
12 Dotan I, Hallak A, Arber N, Santo M, Alexandrowitz A, Knaani Y, Hershkoviz R, Brazowski E, Halpern Z. Low-dose low-molecular weight heparin (enoxaparin) is effective as adjuvant treatment in active ulcerative colitis: an open trial. Dig Dis Sci. 2001;46:2239-2244. [PMID: 11680603 DOI: 10.1023/a:1011979418914] [Cited by in Crossref: 46] [Cited by in F6Publishing: 46] [Article Influence: 2.2] [Reference Citation Analysis]
13 Echtenacher B, Weigl K, Lehn N, Männel DN. Tumor necrosis factor-dependent adhesions as a major protective mechanism early in septic peritonitis in mice. Infect Immun. 2001;69:3550-3555. [PMID: 11349012 DOI: 10.1128/iai.69.6.3550-3555.2001] [Cited by in Crossref: 70] [Cited by in F6Publishing: 71] [Article Influence: 3.3] [Reference Citation Analysis]
14 Salas A, Sans M, Soriano A, Reverter JC, Anderson DC, Piqué JM, Panés J. Heparin attenuates TNF-alpha induced inflammatory response through a CD11b dependent mechanism. Gut 2000;47:88-96. [PMID: 10861269 DOI: 10.1136/gut.47.1.88] [Cited by in Crossref: 98] [Cited by in F6Publishing: 92] [Article Influence: 4.5] [Reference Citation Analysis]
15 Korzenik JR, Hsu A, Robert ME. Effect of heparin on dextran sulfate sodium-induced colitis. Dig Dis Sci. 1998;43:1800-1805. [PMID: 9724172 DOI: 10.1023/a:1018800207063] [Cited by in Crossref: 5] [Cited by in F6Publishing: 7] [Article Influence: 0.2] [Reference Citation Analysis]
16 Björnberg F, Lantz M. Endothelial cell contact potentiates release of soluble tumor necrosis factor (TNF) receptors from the monocyte-like cell line THP-1. J Interferon Cytokine Res 1998;18:167-74. [PMID: 9555978 DOI: 10.1089/jir.1998.18.167] [Reference Citation Analysis]
17 Sack U, Burkhardt U, Borte M, Schädlich H, Berg K, Emmrich F. Age-dependent levels of select immunological mediators in sera of healthy children. Clin Diagn Lab Immunol 1998;5:28-32. [PMID: 9455875 DOI: 10.1128/CDLI.5.1.28-32.1998] [Cited by in Crossref: 67] [Cited by in F6Publishing: 67] [Article Influence: 2.8] [Reference Citation Analysis]
18 Douglas MS, Ali S, Rix DA, Zhang JG, Kirby JA. Endothelial production of MCP-1: modulation by heparin and consequences for mononuclear cell activation. Immunology 1997;92:512-8. [PMID: 9497493 DOI: 10.1046/j.1365-2567.1997.00385.x] [Cited by in Crossref: 34] [Cited by in F6Publishing: 33] [Article Influence: 1.4] [Reference Citation Analysis]
19 Sato H, Sugiyama Y, Tsuji A, Horikoshi I. Importance of receptor-mediated endocytosis in peptide delivery and targeting: kinetic aspects. Advanced Drug Delivery Reviews 1996;19:445-67. [DOI: 10.1016/0169-409x(96)00013-0] [Cited by in Crossref: 20] [Cited by in F6Publishing: 1] [Article Influence: 0.8] [Reference Citation Analysis]
20 Tashiro H, Shimokawa H, Yamamoto K, Nagano M, Momohara M, Muramatu K, Takeshita A. Monocyte-related cytokines in acute myocardial infarction. American Heart Journal 1995;130:446-52. [DOI: 10.1016/0002-8703(95)90350-x] [Cited by in Crossref: 49] [Cited by in F6Publishing: 8] [Article Influence: 1.8] [Reference Citation Analysis]
21 Akhtar I, Gold JP, Pan LY, Ferrara JL, Yang XD, Kim JI, Tan KN. CD4+ beta islet cell-reactive T cell clones that suppress autoimmune diabetes in nonobese diabetic mice. J Exp Med 1995;182:87-97. [PMID: 7790825 DOI: 10.1084/jem.182.1.87] [Cited by in Crossref: 37] [Cited by in F6Publishing: 30] [Article Influence: 1.4] [Reference Citation Analysis]
22 Simpson R, Alon R, Kobzik L, Valeri CR, Shepro D, Hechtman HB. Neutrophil and nonneutrophil-mediated injury in intestinal ischemia-reperfusion. Ann Surg. 1993;218:444-453; discussion 453-454. [PMID: 8215636 DOI: 10.1097/00000658-199310000-00005] [Cited by in Crossref: 163] [Cited by in F6Publishing: 164] [Article Influence: 5.6] [Reference Citation Analysis]